Apellis Pharmaceuticals, Inc. (APLS)
23.49
+0.93
(+4.12%)
USD |
NASDAQ |
Feb 06, 16:00
23.47
-0.02
(-0.09%)
After-Hours: 20:00
Apellis Pharmaceuticals Shareholders Equity (Quarterly) : 401.17M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amneal Pharmaceuticals, Inc. | -109.46M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Amicus Therapeutics, Inc. | 230.42M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Sarepta Therapeutics, Inc. | 1.320B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.059B |
| Total Liabilities (Quarterly) | 657.56M |
| Debt to Equity Ratio | 1.185 |
| Current Ratio | 3.544 |
| Net Debt Paydown Yield | -0.01% |